Pharmafile Logo
Pharmafocus logo
Advanced Search
6813384933_1fb31d73fb_z

Ibalisumab effective in in treating multidrug resistant HIV

August 16, 2018
Research and Development AIDS, HIV, multidrug resistance, phase 3

The monoclonal antibody Ibalizumab has shown significant antiviral activity against multidrug resistant HIV infections, according to the results of a …

News
1280px-old_surgical_hospital_drummond_street

Regenerative process could be restored in liver after severe injuries, study shows

August 16, 2018
Research and Development Edinburgh University, liver, mice, research, transplants

Scientists at the University of Edinburgh were able to restore a regenerative response that prevented the need for a liver …

News

Pfizer partners up with BioNTech for $425m to pursue mRNA flu vaccines

August 16, 2018
Research and Development BioNTech, Pfizer, Vaccine, flu, influenza, pharma

Pfizer has announced a partnership with German biotech firm BioNTech after signing a multi-year deal worth $425 million to develop …

News
dubai

Indian biotech owner detained in Dubai over £550m fraud allegations

August 16, 2018
Medical Communications Dubai, Gujurat, India, Sterling Biotech, UAE, fraud

Indian businessman Nitin Sandesara, the owner of the Gujarat-based pharmaceutical company Sterling Biotech, has been detained in Dubai in relation …

News

Realm Therapeutics shares halved after failure of Phase 2 study

August 15, 2018
Research and Development London, Shares, atopic dermatitis, phase 2, stock market

Shares in the London-listed Realm Therapeutics plummeted on Monday after the company reported that a Phase II study of the …

News

Janssen and ViiV’s monthly injectable HIV combo proves non-inferior to daily standard of care

August 15, 2018
Research and Development HIV, Janssen, ViiV Healthcare, pharma

Janssen and GSK’s ViiV Healthcare have unveiled strong new Phase 3 data on its two-drug regimen, injected once a month, …

News

Rotavirus vaccine shown to reduce risk of death by 34% in Malawi

August 15, 2018
Research and Development Rotavirus, diarrhoea, malawi, vaccination program, vaccines

A rotavirus vaccine was successful in reducing diarrhoea related deaths in infants in Malawi by 34%, a study led by …

News

New York sues Purdue Pharma over opioid crisis

August 15, 2018
Research and Development Litigation, New York, OxyContin, Purude pharma, opioid crisis, state

New York State have sued OxyContin drug maker Purdue Pharma over allegations surrounding widespread fraud and deception in the marketing …

News
gilead-sciences

Gilead CMO announces departure alongside two new exec appointments

August 15, 2018
Medical Communications, Research and Development Gilead, pharma

Gilead has announced that its Chief Medical Officer is to vacate the role after just five months and leave the …

News
charles_hugh_jones

Pfizer CMO Charles Hugh-Jones set to join Allergan in return to New Jersey

August 14, 2018

The Dublin headquartered multinational, Allergan has appointed Pfizer CMO Charles Hugh-Jones as their new Senior Vice President and Chief Medical …

Appointment

Fentanyl execution gets go-ahead in federal court

August 14, 2018
Manufacturing and Production Nebraska, execution, fatalities, fentanyl, valium

The first execution in the United States using the powerful opioid fentanyl, is set to take place in Nebraska on …

News
biogen_austria_238

NICE rejects Biogen’s spinal muscular dystrophy drug Spinraza after long delay

August 14, 2018
Manufacturing and Production, Sales and Marketing Biogen, NICE, Spinraza, UK, pharma, spinal muscular dystrophy

UK watchdog NICE has rejected Biogen’s spinal muscular dystrophy drug Spinraza (nusinersen) over cost concerns, denying patients the only available …

News
staphylococcus_aureus_50000x_usda_ars_emu

Researchers design new class of drugs to counter cardiovascular disease

August 14, 2018
Manufacturing and Production TMAO, cardiovascular, gut microbe, heart attack, research

Cleveland Clinic researchers have designed a potential new class of drugs that may reduce the risk of cardiovascular disease by …

News
cancer-vs-alzheimer-1080x810

“Radical radiotherapy” cuts required treatments from 37 to 5

August 14, 2018
Manufacturing and Production Cancer, oncology, pharma, radiotherapy

Researchers at Queen’s University Belfast have been trialling a new form of “radical radiotherapy” which can be delivered in just …

News
3922609891_dced293244_z

Rare lung cancer drug approved in Scotland

August 14, 2018
Manufacturing and Production Cancer, SMC, Scotland, Scottish Medicines Consortium, approval, lung cancer

The Scottish Medicines Consortium has approved Roche’s cancer drug alectinib for the treatment of patients with untreated advanced non-small-cell lung …

News
nawal_ouzren_-_sensorion_alt

Working Life: Nawal Ouzren, CEO of Sensorion

August 13, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Interview, Sensorion, Working Life, feature, pharma

Pharmafocus caught up with Sensorion CEO Nawal Ouzren to take a look at her path throughout her career and get …

Feature
chris-collins_getty_images

Indicted GOP congressman Chris Collins’ terminates re-election campaign

August 13, 2018
Medical Communications, Sales and Marketing Chris Collins, Innate Therapeutics, US, pharma

Indicted republican congressman Chris Collins has performed a U-turn since his arrest on Wednesday under allegations of insider trading, confirming …

News

Astellas acquires gene therapy group Quethera in £85 million deal

August 13, 2018
Sales and Marketing Astellas, Japan, gene therapy, ocular, quethera, vision

The Japanese company Astellas Pharma has acquired British gene therapy group Quethera in a deal worth up to £85 million. …

News
5204602349_c87b204860_z

FDA approves RNA therapy for rare genetic disease

August 13, 2018
Sales and Marketing FDA, Onpattro, Orphan Drugs, RNA, rare diseases

The US Food and Drug Administration has approved the RNA-based therapy Onpattro, for the treatment of the rare genetic disease …

News
abbvie_0

Chicago Judge overturns $140 million AbbVie AndroGel verdict

August 13, 2018
Sales and Marketing AbbVie, Litigation, androgel, legal, testosterone

A US Judge has overturned a $140.1 million verdict against the New York-listed AbbVie Inc. The verdict, which ruled in …

News
The Gateway to Local Adoption Series

Latest content

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026

Alvotech appoints Lisa Graver as CEO

February 3, 2026

HonorHealth Research Institute announces first patient dosed with new stroke treatment

February 2, 2026

Accord Healthcare appoints Paul Burden as Associate Vice President and Country Head UK

February 2, 2026

Historic UN declaration supporting mental health – treatment to be given similar priority to chronic diseases

January 30, 2026